Fig. 1.
Randomised controlled trials ranked by time from index event to onset of double antithrombotic therapy (DAT) on the left y axis, year of publication on the x axis, and number of patients, anticoagulant used, and clinical presentation indicated by the balloon size, colour and thickness of contour. Duration of triple antithrombotic therapy (TAT) in the right panel. ACS: acute coronary syndrome; DOAC: direct oral anticoagulant; mo: month; VKA: vitamin K antagonist.